| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |